Torbjörn Tomson´s research group
Epilepsy is the commonest serious neurological disease. It affects one in fifty people at some time during their lives. It has many different forms and the causes may vary. Torbjörn Tomson is researching into safer treatment, including treatment with less risk of inducing fetal damage in pregnant women, and also into why some patients die unexpectedly during epileptic fits. He has built up large international collaborative projects, as epilepsy covers a spectrum of conditions, and research requires a large body of patient records.
- Riskfactors for Epilepsia
- Sudden unexpected death in epilepsy (SUDEP)
- Pregnancy and epilepsy
- Pregnancy influences the metabolism of dugs in the body
Antiepileptic treatment in pregnant women: morphological and behavioural effects.
Handb Exp Pharmacol 2011 ;205():295-315
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Lancet Neurol 2011 Jul;10(7):609-17
The impact of background antiepileptic drugs on the efficacy and safety of pregabalin in treating partial-onset seizures: a post hoc analysis of combined clinical trials.
Epilepsy Res. 2011 Sep;96(1-2):64-73
Prior hospitalization for stroke, diabetes, myocardial infarction, and subsequent risk of unprovoked seizures.
Epilepsia 2011 Feb;52(2):301-7
Are lamotrigine kinetics altered in menopause? Observations from a drug monitoring database.
Epilepsy Behav 2010 Sep;19(1):86-8
|Kristina Carlheim-Gyllensköld||Project assistant|
|Olafur Sveinsson||Graduate Student|
|Torbjörn Tomson||Research team leader, Professor/specialist physician|